Latest Rectum Stories

A novel transcriptome-based classification of colon cancer that improves the current disease stratification based on clinicopathological variables and common DNA markers is presented in a study published in PLOS Medicine this week. (A transcriptome is all RNA produced by a population of cells.) Pr. Pierre Laurent-Puig and colleagues from INSERM in Paris, France used genetic information from a French multicenter study supported by the "Ligue contre le cancer" to identify a standard,...

Dr. Allen Kamrava, an associate at Los Angeles Colon and Rectal Surgical Associates, has recently been awarded the “Top Doctor” Achievement from the website HealthTap.com. This award is the Top Colorectal Surgeon in the U.S. Award for Winter 2013. Beverly Hills, CA (PRWEB) April 29, 2013 Dr. Allen Kamrava, Los Angeles Colon and Rectal Surgical Associates (http://www.lacolon.com) in Beverly Hills, has recently been awarded the “Top Doctor” Achievement from the website HealthTap....

Study to Investigate the Safety of Sylys in Colorectal Procedures PITTSBURGH, April 23, 2013 /PRNewswire/ -- Cohera Medical, Inc.(® )(www.coheramedical.com), leading innovator and developer of absorbable surgical adhesives and sealants, today announced the treatment of the first patient in a clinical trial for its latest innovation, Sylys Surgical Sealant, which is designed to reduce leaks in large and small bowel anastomoses. The study, currently underway in Europe, marks a...

Incomplete diagnostic investigation and failure to get the best treatment are the most likely reasons why survival for bowel cancer patients is lower in the UK than in other comparable countries, according to new research published in the journal Acta Oncologica. The research, led by the London School of Hygiene & Tropical Medicine, was carried out in Australia, Canada, Denmark, Norway, Sweden and the UK for the International Cancer Benchmarking Partnership (ICBP). The study included...

Preventing Colorectal Cancer announces that Safeway, Inc. will be the recipient of the 2013 PCC Champion Award of Colon Cancer Prevention for its corporate-wide efforts to advocate colorectal cancer (CRC) screening among its employees. Annapolis, MD (PRWEB) April 09, 2013 Preventing Colorectal Cancer (PCC) announces that Safeway, Inc. will be the recipient of the 2013 PCC Champion Award of Colon Cancer Prevention, an honor the not-for-profit organization established in 2011 to recognize...

GRAND RAPIDS, Mich., April 2, 2013 /PRNewswire/ -- Oncologix Tech Inc. (OTCBB: OCLG), a diversified medical device and healthcare company acquiring businesses in medical device cancer detection and prevention and healthcare services, has purchased all of the outstanding common stock of Dotolo Research Corporation. Dotolo is the leading global colon cleansing and bowel preparation medical device manufacturer, with more than two decades of product research, development and sales....

PE Centers to Participate in 10th Annual Colon Cancer Challenge NEW YORK, April 1, 2013 /PRNewswire/ -- The Colon Cancer Challenge Foundation (CCCF) and Physicians Endoscopy (PE) today announced that they have partnered in the fight against colorectal cancer. Four of the New York City-based endoscopy centers are participating in the annual Colon Cancer Challenge, a running event held in Central Park to raise awareness of colorectal cancer and raise funds for colorectal cancer research, on...

Cancer screening procedure most important for colorectal cancer prevention for people over 50 or those with high risk factors; Colonoscopy recommended once every 10 years KANSAS CITY, Mo., March 26, 2013 /PRNewswire-USNewswire/ -- If you are 50 years old or older, getting a colonoscopy could save your life. March is National Colorectal Cancer Awareness Month, and doctors with Saint Luke's gastroenterology program are encouraging this regular screening for colorectal cancer...

Colon Cancer Awareness Campaign to donate $5 for every story submitted on its website NASHVILLE, Tenn., March 25, 2013 /PRNewswire/ -- With the success of its March 8 National Colon Cancer Screening Day in the record books, StopColonCancerNow.com continues to spread "March Gladness" by raising money for The V Foundation for Cancer Research. (Logo: http://photos.prnewswire.com/prnh/20130306/CL72429LOGO ) In the spirit of this year's basketball-themed "March Gladness" campaign, and...

Stivarga(®) (Regorafenib tablets) demonstrated extended overall survival in patients with Metastatic Colorectal Cancer whose disease progressed after previous treatments TORONTO, March 25, 2013 /CNW/ - Bayer Inc. announced today the Health Canada approval of Stivarga (regorafenib tablets), indicated for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-based chemotherapy, oxaliplatin, irinotecan, an...